Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00014300
What this trial is testing

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 32
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00590954
What this trial is testing

Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Malignant GliomasCNSBrain Cancer+1 more
Memorial Sloan Kettering Cancer Center 32
Not applicableEnded earlyNCT06015295
What this trial is testing

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT02796729
What this trial is testing

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Who this might be right for
Brain Neoplasms, MalignantMetastasis
British Columbia Cancer Agency 3
Testing effectiveness (Phase 2)Study completedNCT00005081
What this trial is testing

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05807165
What this trial is testing

HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases

Who this might be right for
Brain Oligometastases
Chang Gung Memorial Hospital 115
Not applicableUnknownNCT05739500
What this trial is testing

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Who this might be right for
GliomaPrimary Brain Tumor
Mingge LLC 250
Post-approval studies (Phase 4)Study completedNCT01977651
What this trial is testing

Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Astellas Pharma Global Development, Inc. 424
Not applicableLooking for participantsNCT06104930
What this trial is testing

Plasma Extracellular Vesicles in Meningioma Patients

Who this might be right for
Meningioma
University Hospital Heidelberg 60
Testing effectiveness (Phase 2)Looking for participantsNCT06728865
What this trial is testing

Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)EGFR Mutation-Positive Lung CancerBrain Metastases+2 more
Li-kun Chen 70
Not applicableStudy completedNCT00342953
What this trial is testing

Study of Health Effects of Cosmetic Breast Augmentation

Who this might be right for
Brain CancerBreast CancerLung Cancer+1 more
National Cancer Institute (NCI) 17,424
Testing effectiveness (Phase 2)WithdrawnNCT02014545
What this trial is testing

Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT05307328
What this trial is testing

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Who this might be right for
Cushing's Syndrome ICushing Disease Due to Increased ACTH SecretionCortisol Excess+3 more
Sparrow Pharmaceuticals 26
Not applicableStudy completedNCT04691128
What this trial is testing

Desflurane and Brain Relaxation in Craniotomy

Who this might be right for
Supratentorial Tumor
Beijing Tiantan Hospital 111
Testing effectiveness (Phase 2)Study completedNCT00193973
What this trial is testing

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Trans Tasman Radiation Oncology Group 20
Not applicableStudy completedNCT02576522
What this trial is testing

Tumor Bed Hypofractionated IMRT After Surgery for Patients With Single,Large Brain Metastases From Solid Tumor

Who this might be right for
Brain Metastases
Istituto Clinico Humanitas 87
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Testing effectiveness (Phase 2)Study completedNCT02260531
What this trial is testing

Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases

Who this might be right for
Breast CancerBrain Tumor - Metastatic
Dana-Farber Cancer Institute 36
Next Page